This HTML5 document contains 64 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q85015607
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у вересні 2012 գիտական հոդված հրատարակված 2012 թվականի սեպտեմբերի 19-ին artículu científicu espublizáu en setiembre de 2012 wetenschappelijk artikel scientific article published on 19 September 2012
p:P577
wds:Q85015607-B6F87707-8BB6-44FA-A687-B2186D912AB3
wdt:P577
2012-09-19T00:00:00Z
p:P2093
wds:Q85015607-1F552B40-A35A-4105-AA40-C4D37838F020 wds:Q85015607-EE617AAE-5BDF-483A-B7ED-BF4EC4B2B154 wds:Q85015607-BF5D4EEA-57F4-43AD-A612-BC00B3C8E4DE wds:Q85015607-70031FDE-B83E-4239-BC1F-073410EDC3E1
wdt:P2093
Jung-Han Yoon Jung-Sun Kim Seung-Hwan Lee Bum-Kee Hong
rdfs:label
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
skos:prefLabel
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
schema:name
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
p:P50
wds:Q85015607-9EB8212B-8672-4D9C-9972-BAB9F67559D0 wds:Q85015607-A998D946-F72E-4FC1-9073-593D87E0EF89 wds:Q85015607-AB12C0DF-37B7-44B6-B365-FB388AC24CED wds:Q85015607-ABA28ACC-8C08-45C4-9021-507E8E97A2C1 wds:Q85015607-AF9B28BE-F52A-4D95-A963-DF5C493B2DE7 wds:Q85015607-D7F9804F-51CD-4690-AE04-527A70ABCC5C wds:Q85015607-37488CC1-5622-4AA7-9FCC-4411B533AD21 wds:Q85015607-5B475B7D-E24A-4365-9D59-35C97DF64311 wds:Q85015607-6EBE8D4B-72E9-4295-95CE-32C9E707ADF7 wds:Q85015607-7D95DAB3-9C0D-4FE0-AA6C-BC15704D6CAE wds:Q85015607-893FBE2D-E288-4818-A771-E85FECFE6A1A wds:Q85015607-9A2A48FC-D533-431D-A899-34F9EEAD97EE
wdt:P50
wd:Q64147216 wd:Q114435940 wd:Q59566044 wd:Q114435935 wd:Q60327489 wd:Q59695831 wd:Q90731730 wd:Q73843095 wd:Q88740977 wd:Q60571935 wd:Q59679916 wd:Q39371121
p:P1476
wds:Q85015607-C267C3B7-3D7F-43E6-9686-F71D57B4B43C
wdt:P1476
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
p:P304
wds:Q85015607-4C59A01E-80C6-4659-B6D0-21B9ACCD4DDD
wdt:P304
1340-1348
p:P31
wds:Q85015607-7F7DA205-A0C7-411B-A560-163B65106A00
wdt:P31
wd:Q13442814
p:P698
wds:Q85015607-137338CA-833D-4A7C-8697-6877CB9EC1D7
wdtn:P698
n10:22999717
wdt:P698
22999717
p:P1433
wds:Q85015607-E13FBE75-A148-4D47-9028-26789DC057AF
wdt:P1433
wd:Q2984355
p:P433
wds:Q85015607-7433BD1F-3DD3-4396-837A-DEC297549CE1
p:P478
wds:Q85015607-7617A8D7-748A-47B4-80C0-FEC5D1D2618E
wdt:P433
15
wdt:P478
60
p:P356
wds:Q85015607-777AC0FB-BE16-4821-9DFC-6118BC3AFF13
wdtn:P356
n12:J.JACC.2012.06.043
wdt:P356
10.1016/J.JACC.2012.06.043